Related Experiment Videos
Antigenic structure of the Murray Valley encephalitis virus E glycoprotein
R A Hawkes1, J T Roehrig, A R Hunt
1School of Microbiology, University of New South Wales, Australia.
The Journal of General Virology
|May 1, 1988
Summary
Researchers developed new monoclonal antibodies (MAbs) for Murray Valley encephalitis (MVE) virus, finding shared and unique epitopes compared to St. Louis encephalitis (SLE) virus. These findings advance understanding of MVE virus neutralization and protection strategies.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- St. Louis encephalitis (SLE) virus and Murray Valley encephalitis (MVE) virus belong to the same serocomplex.
- Monoclonal antibodies (MAbs) are crucial tools for studying viral antigens and developing diagnostics and therapeutics.
- Existing MAbs against SLE virus prompted the investigation of MVE virus-specific antibodies.
Purpose of the Study:
- To isolate and characterize MAbs that react with MVE virus.
- To compare the antigenic epitopes of MVE virus with those of SLE virus.
- To identify MVE virus-specific epitopes involved in viral neutralization and protection.
Main Methods:
- Isolation and characterization of hybridomas producing MAbs against MVE virus.
- Epitope mapping using a panel of SLE and MVE virus MAbs.
- Assessment of virus-neutralizing and protective capabilities of MAbs in animal models.
Main Results:
- Ten stable hybridomas producing MAbs against MVE virus were established.
- Eight distinct epitopes on the MVE virus envelope (E) glycoprotein were defined.
- Six epitopes were shared with SLE virus, while two new epitopes (E-5 and E-6) were identified on MVE virus.
- The MVE E-1c epitope showed potent virus-neutralizing and protective activity, similar to SLE virus.
- A cross-reactive epitope (E-5) elicited neutralizing antibodies and protected against MVE virus challenge, a novel finding.
Conclusions:
- Antigenic domains within the SLE virus serocomplex are highly conserved.
- Specific epitopes involved in virus neutralization and protection can differ between MVE and SLE viruses.
- The identification of novel, cross-reactive neutralizing epitopes offers potential targets for MVE virus-specific interventions.